Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Fulgent Genetics, Inc. operates as a technology company. The Company develops a proprietary technology platform that integrates sophisticated data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes. Fulgent Genetics offers genetic testing to provide physicians with clinically diagnostic information.
Website: fulgentgenetics.com



Growth: Good revenue growth rate 16.7%, there is acceleration compared to average historical growth rates -14.5%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -81.0%

Profitability: LTM EBITDA margin is negative, -14.9%. On average the margin is improving steadily. Gross margin is high, +42.2%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.37 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 67.2% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 81.2% higher than minimum and 32.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 0.5x by EV / Sales multiple , the company can be >100% undervalued

Insiders: For the last 3 months insiders sold company shares on $0.5 mln (-0.051% of cap.)

Key Financials (Download financials)

Ticker: FLGT
Share price, USD:  (-1.4%)27.69
year average price 21.33  


year start price 16.96 2025-01-22

min close price 15.28 2025-03-03

max close price 30.85 2025-11-25

current price 27.69 2026-01-21
Common stocks: 30 749 000

Dividend Yield:  0.0%
EV / Sales: 0.2x
Margin (EBITDA LTM / Revenue): -14.9%
Fundamental value created in LTM:
Market Cap ($m): 851
Net Debt ($m): -788
EV (Enterprise Value): 63
Price to Book: 0.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-12-23zacks.com

FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform

2025-12-22businesswire.com

Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx

2025-11-07businesswire.com

Fulgent Reports Third Quarter 2025 Financial Results

2025-08-02fool.com

Fulgent (FLGT) Q2 Revenue Jumps 16%

2025-08-01zacks.com

Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates

2025-06-16accessnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT

2025-06-06globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc.  - FLGT

2025-05-28globenewswire.com

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Fulgent Genetics, Inc. (NASDAQ: FLGT) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

2025-05-24businesswire.com

FLGT Investors Have Opportunity to Join Fulgent Genetics, Inc. Fraud Investigation with the Schall Law Firm

2025-05-22globenewswire.com

FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-07 2025-08-01 2024-11-08 2024-08-02 2024-05-03 2024-02-28 2023-11-03 2023-08-04 2023-05-05 2023-02-28 2022-11-07
acceptedDate 2025-11-07 07:14:18 2025-08-01 07:09:52 2024-11-08 07:17:27 2024-08-02 07:38:25 2024-05-03 07:34:20 2024-02-28 17:03:25 2023-11-03 07:31:48 2023-08-04 07:14:47 2023-05-05 07:24:47 2023-02-28 16:49:57 2022-11-07 16:36:02
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 84M 82M 72M 71M 64M 71M 85M 68M 66M 68M 106M
costOfRevenue 49M 47M 45M 47M 44M 47M 45M 47M 47M 55M 60M
grossProfit 36M 34M 27M 25M 20M 23M 40M 21M 19M 13M 46M
grossProfitRatio 0.422 0.421 0.373 0.345 0.312 0.33 0.47 0.303 0.284 0.192 0.436
researchAndDevelopmentExpenses 14M 13M 12M 13M 11M 12M 10M 10M 10M 9M 8M
generalAndAdministrativeExpenses 23M 26M 21M 21M 21M 32M 17M 18M 22M 29M 26M
sellingAndMarketingExpenses 12M 12M 9M 9M 9M 11M 10M 11M 10M 10M 10M
sellingGeneralAndAdministrativeExpenses 35M 39M 30M 30M 30M 42M 28M 29M 32M 39M 36M
otherExpenses 2M 2M 2M 2M 0 -6M 2M 2M 2M 2M 2M
operatingExpenses 51M 54M 44M 43M 42M 54M 40M 40M 44M 50M 46M
costAndExpenses 99M 102M 89M 90M 86M 101M 84M 88M 91M 104M 105M
interestIncome 8M 8M 8M 8M 8M 6M 7M 5M 4M 3M 1M
interestExpense 28 000 17 000 14 000 0 0 36M 54 000 206 000 -4M 3M 1M
depreciationAndAmortization 6M 6M 6M 6M 7M 43 812 6M 6M 2M 2M 2M
ebitda -77 001 -15M -17M -13M -15M -24M 7M -13M -23M -35M 3M
ebitdaratio -0.001 -0.189 -0.238 -0.18 -0.235 -0.345 0.078 -0.199 -0.345 -0.511 0.024
operatingIncome -15M -20M -17M -19M -22M -31M 214 000 -20M -25M -37M 562 000
operatingIncomeRatio -0.183 -0.241 -0.238 -0.266 -0.338 -0.438 0.003 -0.292 -0.375 -0.54 0.005
totalOtherIncomeExpensesNet 9M -2M -1M 8M 8M -114M 7M 5M 4M 3M 1M
incomeBeforeTax -6M -22M -19M -11M -14M -145M 7M -15M -21M -33M 2M
incomeBeforeTaxRatio -0.073 -0.263 -0.258 -0.158 -0.22 -2.059 0.081 -0.217 -0.318 -0.494 0.017
incomeTaxExpense 682 999 -2M -4M -2M -327 000 -11M 20M -3M -5M -9M 414 000
netIncome -7M -19M -15M -9M -13M -128M -13M -11M -16M -24M 1M
netIncomeRatio -0.079 -0.232 -0.204 -0.123 -0.209 -1.818 -0.155 -0.165 -0.24 -0.356 0.013
eps -0.21 -0.61 -0.48 -0.29 -0.45 -4.3 -0.44 -0.38 -0.54 -0.81 0.045
epsdiluted -0.21 -0.61 -0.48 -0.29 -0.45 -4.3 -0.44 -0.38 -0.54 -0.81 0.044
weightedAverageShsOut 31M 31M 30M 30M 30M 30M 30M 30M 30M 30M 30M
weightedAverageShsOutDil 31M 31M 30M 30M 30M 30M 30M 30M 30M 30M 31M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-07 2025-08-01 2024-11-08 2024-08-02 2024-05-03 2024-02-28 2023-11-03 2023-08-04 2023-05-05 2023-02-28 2022-11-07
acceptedDate 2025-11-07 07:14:18 2025-08-01 07:09:52 2024-11-08 07:17:27 2024-08-02 07:38:25 2024-05-03 07:34:20 2024-02-28 17:03:25 2023-11-03 07:31:48 2023-08-04 07:14:47 2023-05-05 07:24:47 2023-02-28 16:49:57 2022-11-07 16:36:02
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 118M 88M 58M 65M 55M 97M 84M 58M 66M 80M 169M
shortTermInvestments 258M 205M 155M 247M 251M 327M 384M 400M 805M 773M 749M
cashAndShortTermInvestments 376M 293M 213M 312M 306M 424M 468M 458M 871M 853M 918M
netReceivables 79M 85M 57M 64M 59M 57M 55M 40M 44M 53M 104M
inventory 10M 9M 9M 7M 7M 6M 5M 6M 5M 4M 8M
otherCurrentAssets 43M 42M 48M 17M 21M 26M 33M 35M 33M 22M 10M
totalCurrentAssets 507M 429M 327M 399M 387M 508M 550M 528M 915M 906M 1 022M
propertyPlantEquipmentNet 112M 110M 107M 103M 96M 94M 85M 88M 79M 81M 82M
goodwill 25M 22M 22M 22M 22M 22M 142M 142M 143M 143M 120M
intangibleAssets 135M 131M 137M 139M 141M 143M 144M 146M 149M 151M 88M
goodwillAndIntangibleAssets 160M 153M 159M 161M 163M 165M 286M 288M 292M 294M 208M
longTermInvestments 412M 484M 602M 547M 561M 444M 399M 401M 380M 339M 358M
taxAssets 0 0 0 0 0 30M 0 0 0 0 0
otherNonCurrentAssets 23M 23M 39M 23M 23M 32M 38M 49M -289M -234M -265M
totalNonCurrentAssets 707M 771M 907M 833M 843M 765M 809M 826M 462M 480M 384M
otherAssets 0 0 0 0 0 1 0 0 0 0 0
totalAssets 1 215M 1 200M 1 234M 1 232M 1 230M 1 273M 1 358M 1 355M 1 377M 1 386M 1 406M
accountPayables 18M 19M 20M 20M 20M 15M 16M 21M 22M 23M 14M
shortTermDebt 2M 2M 412 000 3M 4M 6M 3M 5M 21M 21M 20M
taxPayables 0 0 0 0 0 0 0 0 0 0 426 000
deferredRevenue 31M 30M 27M 3M 3M 3M 21M 17M 14M 14M 28M
otherCurrentLiabilities 22M 21M 27M 24M 50M 49M 21M 23M 51M 58M 61M
totalCurrentLiabilities 72M 71M 74M 76M 76M 73M 61M 65M 108M 116M 124M
longTermDebt 6M 6M 0 10M 2M 10M 3M 0 0 0 0
deferredRevenueNonCurrent 0 0 0 8M 7M -888 000 -3M 0 0 0 0
deferredTaxLiabilitiesNonCurrent 7M 6M 7M 13M 13M 52M 10M 10M 0 0 0
otherNonCurrentLiabilities 9M 5M 18M 4M 5M 6M 25M 17M 26M 28M -42M
totalNonCurrentLiabilities 21M 17M 25M 28M 27M 67M 35M 26M 26M 28M 22M
otherLiabilities 0 0 0 0 0 0 0 0 -26M -28M -22M
capitalLeaseObligations 5M 5M 0 10M 7M 9M 10M 11M 0 0 0
totalLiabilities 94M 88M 99M 103M 103M 140M 97M 91M 108M 116M 124M
preferredStock 0 0 0 20M 20M 20M 15M 13M 13M 0 0
commonStock 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000 3000
retainedEarnings 553M 560M 596M 611M 620M 633M 761M 774M 786M 801M 825M
accumulatedOtherComprehensiveIncomeLoss 7M 6M 9M -877 000 -1M 1M -17M -21M -17M -21M -26M
othertotalStockholdersEquity 566M 551M 533M 522M 491M 481M 499M 493M 487M 490M 482M
totalStockholdersEquity 1 126M 1 117M 1 138M 1 133M 1 130M 1 136M 1 259M 1 260M 1 269M 1 270M 1 281M
totalEquity 1 121M 1 112M 1 135M 1 129M 1 127M 1 133M 1 262M 1 263M 1 273M 1 270M 1 281M
totalLiabilitiesAndStockholdersEquity 1 215M 1 200M 1 234M 1 232M 1 230M 1 273M 1 358M 1 355M 1 377M 1 386M 1 406M
minorityInterest -5M -5M -4M -4M -3M -3M 3M 4M 4M 3M 0
totalLiabilitiesAndTotalEquity 1 215M 1 200M 1 234M 1 232M 1 230M 1 273M 1 358M 1 355M 1 377M 1 386M 1 406M
totalInvestments 670M 690M 757M 793M 812M 771M 767M 788M 805M 786M 760M
totalDebt 8M 7M 412 000 13M 13M 15M 3M 5M 21M 21M 20M
netDebt -110M -80M -58M -52M -42M -83M -81M -54M -46M -59M -148M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT FLGT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-07 2025-08-01 2024-11-08 2024-08-02 2024-05-03 2024-02-28 2023-11-03 2023-08-04 2023-05-05 2023-02-28 2022-11-07
acceptedDate 2025-11-07 07:14:18 2025-08-01 07:09:52 2024-11-08 07:17:27 2024-08-02 07:38:25 2024-05-03 07:34:20 2024-02-28 17:03:25 2023-11-03 07:31:48 2023-08-04 07:14:47 2023-05-05 07:24:47 2023-02-28 16:49:57 2022-11-07 16:36:02
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome -7M -19M -15M -9M -13M -128M -13M -12M -16M -24M 1M
depreciationAndAmortization 6M 6M 6M 6M 7M 7M 6M 6M 7M 10M 10M
deferredIncomeTax -701 000 24 000 -2M -457 000 -557 000 502 000 19M -3M -5M 5M 3M
stockBasedCompensation 10M 10M 11M 12M 12M 11M 11M 10M 10M 10M 9M
changeInWorkingCapital 2M -39M -2M -3M 5M 10M -11M 9M -5M 23M -11M
accountsReceivables 5M -8M -2M -3M 1M -5M -12M 10M 9M 44M 22M
inventory 0 0 0 0 0 0 0 0 0 0 0
accountsPayables -102 000 386 000 2M 2M -245 000 129 000 -3M -3M -2M 7M -22M
otherWorkingCapital -2M -31M -3M -2M 4M 15M 3M 843 000 -7M -28M -12M
otherNonCashItems 495 000 11M -12M 23M 22M 114M -2M -668 000 791 000 10M 9M
netCashProvidedByOperatingActivities 11M -30M -16M 4M 7M 15M 10M 10M -8M 33M 21M
investmentsInPropertyPlantAndEquipment -6M -7M -20M -13M -4M -3M -5M -12M -2M 5M -5M
acquisitionsNet 0 0 -275 000 17 000 258 000 -64 000 22 000 220 000 0 -45M 0
purchasesOfInvestments -19M 0 -115M -63M -196M -148M -93M -107M -144M -161M -12M
salesMaturitiesOfInvestments 40M 60M 144M 83M 152M 176M 118M 117M 141M 108M 61M
otherInvestingActivites 4M 0 313 000 20M 258 000 28M 25M 0 198 000 172 000 222 000
netCashUsedForInvestingActivites 19M 53M 9M 7M -47M 24M 20M -1M -4M -93M 44M
debtRepayment -88 000 -88 000 -136 000 -602 000 -900 000 -11M -2M -16M -232 000 -231 000 -238 000
commonStockIssued 0 0 0 0 0 -3000 0 3000 0 31 000 0
commonStockRepurchased -357 000 -3M -431 000 -544 000 -225 000 -24M -2M -232 000 0 -29M -35M
dividendsPaid 0 0 0 0 0 0 0 -229 000 0 0 0
otherFinancingActivites 0 0 0 -544 000 -2M -13M -517 000 229 000 -869 000 -335 000 -522 000
netCashUsedProvidedByFinancingActivities -445 000 -3M -567 000 -1M -3M -26M -4M -16M -1M -30M -35M
effectOfForexChangesOnCash 15 000 4000 157 000 -9000 -69 000 145 000 -116 000 -206 000 28 000 -279 000 387 000
netChangeInCash 30M 21M -7M 10M -43M 13M 26M -8M -13M -89M 30M
cashAtEndOfPeriod 118M 88M 58M 65M 55M 97M 84M 58M 66M 80M 169M
cashAtBeginningOfPeriod 88M 67M 65M 55M 97M 84M 58M 66M 80M 169M 139M
operatingCashFlow 11M -30M -16M 4M 7M 15M 10M 10M -8M 33M 21M
capitalExpenditure -6M -7M -20M -13M -4M -3M -5M -12M -2M 5M -5M
freeCashFlow 5M -37M -35M -9M 3M 12M 5M -2M -10M 38M 15M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q3
2025-11-07 ET (fiscal 2025 q3)
2025 q2
2025-08-01 ET (fiscal 2025 q2)
2025 q1
2025-05-02 ET (fiscal 2025 q1)
2024 q4
2025-02-28 ET (fiscal 2024 q4)
2024 q3
2024-11-11 ET (fiscal 2024 q3)
2024 q2
2024-08-02 ET (fiscal 2024 q2)
2024 q1
2024-05-03 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-11-03 ET (fiscal 2023 q3)
2023 q2
2023-08-04 ET (fiscal 2023 q2)
2023 q1
2023-05-05 ET (fiscal 2023 q1)
2022 q4
2023-02-28 ET (fiscal 2022 q4)
2022 q3
2022-11-07 ET (fiscal 2022 q3)
2022 q2
2022-08-04 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-07 07:14 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-11-07 07:10 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-11-07 07:10 ET
Fulgent Genetics reported for 2025 q3
SEC form 8
2025-11-07 07:10 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-10-20 10:04 ET
Fulgent Genetics published news for 2025 q3
SEC form 8
2025-10-20 10:04 ET
Fulgent Genetics published news for 2025 q3
SEC form 10
2025-08-01 07:09 ET
Fulgent Genetics reported for 2025 q2
SEC form 8
2025-08-01 07:05 ET
Fulgent Genetics published news for 2025 q2
SEC form 8
2025-08-01 07:05 ET
Fulgent Genetics published news for 2025 q2
SEC form 8
2025-08-01 07:05 ET
Fulgent Genetics published news for 2025 q2
SEC form 10
2025-05-02 11:14 ET
Fulgent Genetics published news for 2025 q1
SEC form 8
2025-05-02 11:10 ET
Fulgent Genetics published news for 2025 q1
SEC form 8
2025-05-02 11:10 ET
Fulgent Genetics reported for 2025 q1
SEC form 8
2025-05-02 11:10 ET
Fulgent Genetics published news for 2025 q1
SEC form 10
2025-05-02 00:00 ET
Fulgent Genetics published news for 2025 q1
SEC form 10
2025-02-28 07:15 ET
Fulgent Genetics reported for 2024 q4
SEC form 8
2025-02-28 07:10 ET
Fulgent Genetics published news for 2024 q4
SEC form 8
2025-02-28 07:10 ET
Fulgent Genetics published news for 2024 q4
SEC form 8
2025-02-28 07:10 ET
Fulgent Genetics published news for 2024 q4
SEC form 10
2025-02-28 00:00 ET
Fulgent Genetics published news for 2024 q4
SEC form 10
2024-11-08 07:17 ET
Fulgent Genetics reported for 2024 q3
SEC form 8
2024-11-08 07:10 ET
Fulgent Genetics published news for 2024 q3
SEC form 8
2024-11-08 07:10 ET
Fulgent Genetics published news for 2024 q3
SEC form 8
2024-11-08 07:10 ET
Fulgent Genetics published news for 2024 q3
SEC form 10
2024-08-02 07:38 ET
Fulgent Genetics published news for 2024 q2
SEC form 8
2024-08-02 07:09 ET
Fulgent Genetics published news for 2024 q2
SEC form 8
2024-08-02 07:09 ET
Fulgent Genetics reported for 2024 q2
SEC form 8
2024-08-02 07:09 ET
Fulgent Genetics published news for 2024 q2
SEC form 10
2024-08-02 00:00 ET
Fulgent Genetics published news for 2024 q2
SEC form 10
2024-05-03 07:34 ET
Fulgent Genetics published news for 2024 q1
SEC form 8
2024-05-03 07:05 ET
Fulgent Genetics published news for 2024 q1
SEC form 8
2024-05-03 07:05 ET
Fulgent Genetics reported for 2024 q1
SEC form 8
2024-05-03 07:05 ET
Fulgent Genetics published news for 2024 q1
SEC form 10
2024-05-03 00:00 ET
Fulgent Genetics published news for 2024 q1
SEC form 10
2024-02-28 17:03 ET
Fulgent Genetics published news for 2023 q4
SEC form 8
2024-02-28 07:08 ET
Fulgent Genetics published news for 2023 q4
SEC form 8
2024-02-28 07:08 ET
Fulgent Genetics reported for 2023 q4
SEC form 8
2024-02-28 07:08 ET
Fulgent Genetics published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Fulgent Genetics published news for 2023 q4
SEC form 10
2023-11-03 07:31 ET
Fulgent Genetics published news for 2023 q3
SEC form 8
2023-11-03 07:09 ET
Fulgent Genetics reported for 2023 q3
SEC form 10
2023-11-03 00:00 ET
Fulgent Genetics published news for 2023 q3
SEC form 10
2023-08-04 07:14 ET
Fulgent Genetics reported for 2023 q2
SEC form 6
2023-08-04 07:07 ET
Fulgent Genetics published news for 2023 q2
SEC form 10
2023-08-04 00:00 ET
Fulgent Genetics published news for 2023 q2
SEC form 8
2023-08-04 00:00 ET
Fulgent Genetics published news for 2023 q2
SEC form 10
2023-05-05 00:00 ET
Fulgent Genetics published news for 2023 q1
SEC form 8
2023-05-05 00:00 ET
Fulgent Genetics published news for 2023 q1
SEC form 10
2023-02-28 16:49 ET
Fulgent Genetics reported for 2022 q4
SEC form 6
2023-02-28 16:24 ET
Fulgent Genetics published news for 2022 q4
SEC form 10
2023-02-28 00:00 ET
Fulgent Genetics reported for 2022 q4
SEC form 8
2023-02-28 00:00 ET
Fulgent Genetics reported for 2022 q4
SEC form 6
2023-01-12 16:10 ET
Fulgent Genetics published news for 2022 q4
SEC form 6
2023-01-04 16:34 ET
Fulgent Genetics published news for 2022 q4
SEC form 6
2023-01-03 16:11 ET
Fulgent Genetics published news for 2022 q4
SEC form 6
2022-11-23 16:09 ET
Fulgent Genetics published news for 2022 q3
SEC form 10
2022-11-07 16:36 ET
Fulgent Genetics reported for 2022 q3
SEC form 6
2022-11-07 16:11 ET
Fulgent Genetics published news for 2022 q3
SEC form 10
2022-11-07 00:00 ET
Fulgent Genetics reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
Fulgent Genetics reported for 2022 q3
SEC form 6
2022-11-04 16:05 ET
Fulgent Genetics published news for 2022 q3
SEC form 6
2022-09-29 16:15 ET
Fulgent Genetics published news for 2022 q2
SEC form 6
2022-08-10 18:06 ET
Fulgent Genetics published news for 2022 q2
SEC form 10
2022-08-04 17:03 ET
Fulgent Genetics reported for 2022 q2
SEC form 6
2022-08-04 16:39 ET
Fulgent Genetics published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Fulgent Genetics reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Fulgent Genetics reported for 2022 q2
SEC form 6
2022-08-03 17:34 ET
Fulgent Genetics published news for 2022 q2
SEC form 6
2022-06-30 16:07 ET
Fulgent Genetics published news for 2022 q1
SEC form 6
2022-05-19 16:19 ET
Fulgent Genetics published news for 2022 q1
SEC form 10
2022-05-05 16:51 ET
Fulgent Genetics reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Fulgent Genetics reported for 2022 q1
SEC form 6
2022-05-03 16:10 ET
Fulgent Genetics published news for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Fulgent Genetics reported for 2022 q1
SEC form 6
2022-04-26 16:43 ET
Fulgent Genetics published news for 2022 q1
SEC form 6
2022-04-18 16:13 ET
Fulgent Genetics published news for 2022 q1
SEC form 6
2022-03-29 16:33 ET
Fulgent Genetics published news for 2021 q4
SEC form 6
2022-03-29 16:23 ET
Fulgent Genetics published news for 2021 q4
SEC form 10
2022-02-28 08:13 ET
Fulgent Genetics published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Fulgent Genetics published news for 2021 q4
SEC form 6
2022-02-23 16:10 ET
Fulgent Genetics published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
Fulgent Genetics published news for 2021 q4
SEC form 10
2021-11-09 17:13 ET
Fulgent Genetics published news for 2021 q3
SEC form 6
2021-11-09 16:11 ET
Fulgent Genetics published news for 2021 q3
SEC form 10
2021-11-09 00:00 ET
Fulgent Genetics published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Fulgent Genetics published news for 2021 q3
SEC form 10
2021-08-10 00:00 ET
Fulgent Genetics published news for 2021 q2
SEC form 10
2021-08-09 21:32 ET
Fulgent Genetics published news for 2021 q2
SEC form 6
2021-08-09 16:25 ET
Fulgent Genetics published news for 2021 q2
SEC form 6
2021-05-20 17:12 ET
Fulgent Genetics published news for 2021 q1
SEC form 10
2021-05-07 16:07 ET
Fulgent Genetics published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Fulgent Genetics published news for 2021 q1
SEC form 6
2021-05-06 16:20 ET
Fulgent Genetics published news for 2021 q1
SEC form 6
2021-04-01 16:16 ET
Fulgent Genetics published news for 2021 q1
SEC form 10
2021-03-08 17:17 ET
Fulgent Genetics published news for 2020 q4
SEC form 6
2021-03-04 16:07 ET
Fulgent Genetics published news for 2020 q4
SEC form 6
2021-02-05 16:40 ET
Fulgent Genetics published news for 2020 q4
SEC form 6
2020-12-22 17:08 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-11-23 08:12 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-11-20 17:03 ET
Fulgent Genetics published news for 2020 q3
SEC form 10
2020-11-09 16:24 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-11-09 16:11 ET
Fulgent Genetics published news for 2020 q3
SEC form 6
2020-10-21 16:17 ET
Fulgent Genetics published news for 2020 q3